AC
ACTION: Anti-Cytokine Therapy for Hemodialysis Inflammation Trial
Jonathan Himmelfarb
NIDDK HDNT Consortium
Jonathan Himmelfarb, MD
AS
ASCEND: A Trial of Sertraline vs. CBT for End-Stage Renal Disease Patients with Depression
Rajnish Mehrotra
PCORI
AS
ASPIRED: Assessing Patient-Reported Experience of Care for Home Dialysis
Matthew Rivara
Satellite Healthcare
AS
ASSESS-AKI: Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury
Jonathan Himmelfarb
NIDDK
Jonathan Himmelfarb, MD
Bi
Bio-PD: Biological Determinants of Peritoneal Dialysis
Rajnish Mehrotra
NIDDK
CA
CANDY CANE: Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease – Changing Glucose Management
Ian de Boer
ADA
CA
CANDY: Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease
Ian de Boer
ADA
CA
CATCH: A Prospective Clinical Study to EvaluAte the AbiliTy of the CloudCath System to Detect Peritonitis
Rajnish Mehrotra
GastroKlenz, Inc. (CloudCath)
Ce
Cellular and Molecular Mechanisms of COVID-19 Mediated Kidney Injury
Jonathan Himmelfarb
NCATS
Jonathan Himmelfarb, MD
CH
CHROME: COVID-19 Host Response and Clinical Outcomes
Mark Wurfel
The Gates Foundation
CL
CLEAR: Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease
Ian de Boer
NIDDK
Co
CoNR: Cross-over Randomized Controlled Trial of Coenzyme Q10 or Nicotinamide Riboside in Chronic Kidney Disease
Bryan Kestenbaum
NIDDK
ED
EDEN-EPO Dosing for Anemia in End-Stage Kidney Disease
Jonathan Himmelfarb
NIH
ES
ESTEEM: Exercise Study Testing Enhanced Energetics of Muscle Mitochondria in Chronic Kidney Disease
Baback Roshanravan
NIDDK
Baback Roshanravan, MD
Ex
Experiences of older adults with kidney failure and their family members related to the transplant evaluation process
Kate Butler
NIDDK
GL
GLUTE: Randomized Trial of Glutamine in Chronic Kidney Disease
Jonathan Himmelfarb
NIDDK / NY Medical College
Jonathan Himmelfarb, MD
HO
HOPE:The Hemodialysis Opioid Prescription Effort Consortium
Rajnish Mehrotra
NIH
IC
ICICLE: Impact of Cirrhosis on Kidney Secretory Clearance
Bryan Kestenbaum
UW Royalty Research Fund
Id
Identification of AKI Sub-phenotypes Based on Trajectory of Serum Creatinine
Pavan Bhatraju
Pulmonary and Critical Care…
Lo
Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease
Nisha Bansal
LU
LUCID: Longitudinal U.S./Canada Incident Dialysis Study
Jonathan Himmelfarb
Massachusetts General Hospital
Jonathan Himmelfarb, MD
ME
MEND: Muscle Mitochondria Energetics in Chronic Kidney Disease
Bryan Kestenbaum
NIDDK
NI
NIRVANA: Nicotinamide Riboside in SARS-CoV-2 patients for renal protection
Bryan Kestenbaum
PD
PDOPPS: Peritoneal Dialysis Outcomes and Practice Patterns Study
Rajnish Mehrotra
NIDDK
PO
POM: Pomegranate and Hemodialysis Pilot Trial
Jonathan Himmelfarb
POM Wonderful, LLC
PR
PROCLAIM: Proximal Tubule Clearance of Renal Medications Study
Bryan Kestenbaum
NIDDK
SM
SMART: Smart Phone Application to Improve Renal Transplants
Christopher Blosser
TapCloud, LLC
Sp
Spin-D: Safety and Cardiovascular Efficacy on Spironolactone in Hemodialysis Patients
Jonathan Himmelfarb
NIDDK
Jonathan Himmelfarb, MD